Magellan Health Board of Directors Appoints David Haddock as General Counsel and Secretary of Magellan Health
February 03 2020 - 12:00PM
Business Wire
Magellan Health, Inc. (NASDAQ: MGLN) today announced that the
Company’s Board of Directors has appointed David Haddock as general
counsel and secretary of Magellan Health, effective Monday,
February 3, 2020. In this role, he will be responsible for
providing company-wide legal, compliance and regulatory
leadership.
“David is a superb leader with significant experience leading
complex legal matters for publicly held and highly regulated
organizations over a 25-year legal career,” said Ken Fasola, chief
executive officer, Magellan Health. “The Board and I look forward
to working with David who will serve as a trusted business partner
and advisor for our Company on a wide range of strategic business
matters on behalf of our customers, members and shareholders.”
“I look forward to joining the Magellan Health leadership team
and am honored to have been chosen for this vital role in the
Company,” said Haddock. “I’m excited to lead and start working with
the outstanding legal, compliance and regulatory departments as we
continue our steadfast commitment to guiding and supporting the
needs of our businesses,” said Haddock.
Prior to joining Magellan, Haddock was the general counsel and
corporate secretary at Quality Care Properties, Inc. (QCP), in
Bethesda, Maryland, where he advised the Board of Directors, CEO
and senior management on all legal matters pertinent to QCP. From
2010-2013, Haddock served as the general counsel and corporate
secretary at a Sunrise Senior Living, Inc., in McLean,
Virginia.
Haddock has a bachelor’s degree in English from Princeton
University and earned his juris doctorate from the University of
Virginia School of Law.
About Magellan Health: Magellan Health, Inc., a Fortune
500 company, is a leader in managing the fastest growing, most
complex areas of health, including special populations, complete
pharmacy benefits and other specialty areas of healthcare. Magellan
supports innovative ways of accessing better health through
technology, while remaining focused on the critical personal
relationships that are necessary to achieve a healthy, vibrant
life. Magellan's customers include health plans and other managed
care organizations, employers, labor unions, various military and
governmental agencies and third-party administrators. For more
information, visit MagellanHealth.com.
Forward-Looking Statements
This release is intended to be disclosure through methods
reasonably designed to provide broad, non-exclusionary distribution
to the public in compliance with the Securities and Exchange
Commission’s Fair Disclosure Regulation. This release contains
forward-looking statements within the meaning of the Securities
Exchange Act of 1934 and the Securities Act of 1933, as amended,
which involve a number of risks and uncertainties, many of which
are out of our control. All statements, other than statements of
historical information provided herein, may be deemed to be
forward-looking statements including, without limitation,
statements regarding growth and strategy. These statements are
based on management’s analysis, judgment, belief and expectation
only as of the date hereof, and are subject to uncertainty and
changes in circumstances. Without limiting the foregoing, the words
“believes,” “anticipates,” “plans,” “expects,” “may,” “should,”
“could,” “estimate,” “intend” and other similar expressions are
intended to identify forward-looking statements. Actual results
could differ materially due to, among other things, the possible
election of certain of the Company’s customers to manage the
healthcare services of their members directly; changes in rates
paid to and/or by the Company by customers and/or providers; higher
utilization of healthcare services by the Company’s risk members;
delays, higher costs or inability to implement new business or
other Company initiatives; the impact of changes in the contracting
model for Medicaid contracts; termination or non-renewal of
customer contracts; the impact of new or amended laws or
regulations; governmental inquiries; litigation; competition;
operational issues; healthcare reform; and general business
conditions. Additional factors that could cause actual results to
differ materially from those reflected in the forward-looking
statements include, but are not limited to, the risks discussed in
the “Risk Factors” section included within the Company’s Annual
Report on Form 10-K for the year ended December 31, 2018, filed
with the Securities and Exchange Commission on February 28, 2019,
and the Company’s subsequent Quarterly Reports on Form 10-Q filed
during 2019. Readers are cautioned not to place undue reliance on
these forward-looking statements. The Company undertakes no
obligation to publicly revise these forward-looking statements to
reflect events or circumstances that arise after the date of this
release. Segment profit, adjusted net income, and adjusted EPS
information referred to herein may be considered a non-GAAP
financial measure. Further information regarding these measures,
including the reasons management considers this information useful
to investors, are included in the Company’s most recent Annual
Report on Form 10-K and on subsequent Form 10-Qs.
(MGLN-GEN)
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200203005580/en/
Media Contact: Lilly Ackley, ackleyl@magellanhealth.com,
(860) 507-1923 Investor Contact: Joe Bogdan,
jbogdan@magellanhealth.com, (860) 507-1910
Magellan Health (NASDAQ:MGLN)
Historical Stock Chart
From Feb 2024 to Mar 2024
Magellan Health (NASDAQ:MGLN)
Historical Stock Chart
From Mar 2023 to Mar 2024